Navigation Links
New engineered drug may offer prolonged arthritis relief

to be effective."

To build in such durability, Betre turned to a class of proteins called elastin-like polypeptides (ELPs). Once ELPs in solution reach a certain threshold temperature, they assemble into protein aggregates. Study collaborator Ashutosh Chilkoti, a professor of biomedical engineering at the Pratt School, previously had investigated the use of ELPs that clump at temperatures higher than normal body temperature for treating cancers.

ELPs aren't recognized by the body's immune system as foreign substances, and thus they have some unique advantages for biomedical applications, according to the researchers. Also, ELPs can be joined directly to genes that control the production of various proteins in cells, with the combination forming "fusion proteins." As the proteins degrade, they yield simple amino acids, which are the building blocks of all proteins.

By experimenting with composition, molecular weight and concentration of various ELPs, Betre developed a protein for use in joints that would precipitate out of solution and clump at normal body temperature.

When he injected the sticky ELP into the knees of rats, the protein proved to have a 25-fold longer half-life in the joint than a similar soluble protein, Betre reported in the journal article. Half-life is the time required for half the quantity of the protein to be broken down and eliminated from the joint space.

"At 12 hours, the soluble protein was already at a concentration in the joint below 10 percent of the injected dose," Setton said.

In contrast, the sticky ELP took about two weeks to fall to the 10 percent level in the animals' joints -- a "really substantial increase," she said.

Moreover, rats injected with the clumping ELP contained lower blood levels of the protein, suggesting that a protein drug paired to the ELP might also have the benefit of fewer side effects, Shamji said. This would be important, he said, because IL1RA c
'"/>

Source:Duke University


Page: 1 2 3 4

Related biology news :

1. Insects develop resistance to engineered crops
2. Genetically engineered animals help in scientific research that may benefit children
3. Genetically engineered mosquitoes show resistance to dengue fever virus
4. Bioengineered tissue implants regenerate damaged knee cartilage
5. Genetically engineered blood protein can be used to split water into oxygen and hydrogen
6. Can engineered immune cells stop AIDS?
7. Tissue engineered scaffolding allows reproduction of cartilage tissue
8. Ancient olfaction protein is shared by many bugs, offering new pest control target
9. Protein offers way to stop microscopic parasites in their tracks
10. Nanoparticles offer new hope for detection and treatment
11. Whats really making you sick? Plant pathologists offer the science behind Sick Building Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New engineered drug may offer prolonged arthritis relief

(Date:7/8/2015)... N.J. and NEW YORK , July 8, ... Guidepoint today announced BD & Guidepoint Mentor, ... with free access to Guidepoint,s expert network services. ... are developing cutting-edge technologies to improve healthcare delivery and ... research manager, each start-up entrepreneur will be able to ...
(Date:7/7/2015)... , July 7, 2015  Based on its ... & Sullivan recognizes Credence ID, LLC with the ... Company of the Year Award. Credence ID has ... in its mission of offering enrollment and identification ... As Credence ID was formed by experts from ...
(Date:7/2/2015)... Fingerprint Cards has received an order ... from the distributor World Peace Industrial Group (WPI), part of ... Asia . Deliveries are planned to take place ... by smartphone manufacturers in Asia . The ... revenue guidance of approximately 2,200 MSEK for 2015. ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
... a global provider of semiconductor die and specialized packaging ... U.S. Senator George LeMieux (R-FL) to its corporate headquarters. ... Promotion Act (bipartisan legislation aimed at increasing export trade ... to review, firsthand, how federal export promotion could expand ...
... 2010The easy accessibility of the eye and the established ... hope for using gene therapy to provide long-term therapeutic ... Gene Therapy, a peer-reviewed journal published by Mary Ann ... of a human gene to preserve photoreceptor function in ...
... in Marin County, Calif., a fierce battle is taking place ... a battle between an invasive plant and a native plant, ... and Tidestrom,s lupine, are not in direct competition, and yet ... cliff. European beachgrass provides cover that allows a timid ...
Cached Biology News:Chip Supply Hosts Visit by U.S. Senator George LeMieux 2Promising results of gene therapy to treat diseases of the eye 2Trojan Horse attack on native lupine 2Trojan Horse attack on native lupine 3Trojan Horse attack on native lupine 4Trojan Horse attack on native lupine 5Trojan Horse attack on native lupine 6
(Date:7/29/2015)... England , July 29, 2015  Indivior PLC ... (NDA) for naloxone nasal spray was accepted and received ... (FDA) for the treatment of opioid overdose. This naloxone ... naloxone specially formulated for optimal absorption into the nasal ... require minimal training so individuals may be better equipped ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... a Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi LifeSciences is ... services. The core expertise of PRC Clinical is focused on Clinical Trial Management, ...
(Date:7/29/2015)... , ... July 29, 2015 , ... Nearly everyone has ... diseases. Yet few people realize that a rich source of these cells is teeth—baby ... and teeth that need to be pulled to make room for braces. These ...
(Date:7/28/2015)... -- People with a common form of hearing loss ... profound improvements in their hearing and understanding of speech ... multicenter study led by specialists at NYU Langone Medical ... of print in the journal The Laryngoscope July 7, researchers ... the United States implanted hybrid cochlear ...
Breaking Biology Technology:Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Advanced Oral and Maxillofacial Surgery (AOMS) in Elmhurst, IL Partners with Provia Labs to make Store-A-Tooth™ Dental Stem Cell Banking Available to their Patients 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3
... 21, 2012 International scientific and government experts ... potential use of Oxitec,s genetically modified Aedes aegypti ... The independent forum was co-organised by the Smithsonian ... Studies and the University of Panama. This brought together national ...
... ROCKVILLE, Md., May 21, 2012  Neuralstem, Inc. (NYSE ... President, will present at the World Stem Cells ... ) on Tuesday, May 22nd at 12:30 PM. ... Disorders," will review Neuralstem,s cellular therapy trial in ...
... 18, 2012 Champions Oncology Inc. (OTC: CSBR) announced ... Amendment (CLIA) certification from the Maryland Department of Health ... for the company to conduct medical laboratory tests. ... "Obtaining CLIA approval is a significant milestone for our ...
Cached Biology Technology:Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama 2Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama 3Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London 2Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities 2Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities 3
... High perfomance data acquisition interface. All the ... faster on-board processor, increased memory and more ... The Power1401 also inlcudes an option for ... the standard 16 to 48 waveform inputs ...
MAb to Yersinia pestis F1 Ag. Yersinia pestis F1 Antigen EB Strain...
Mouse monoclonal antibody to QDPR - quinoid dihydropteridine reductase...
... System consists of FAST RED chromogen,tablets and ... presence of alkaline phosphatase to produce red ... FAST RED System provides enough material for ... , Vial A: 6 Tablets , Vial ...
Biology Products: